Resultats de la cerca - Basu, Supratik

Haematological manifestations of COVID‐19: From cytopenia to coagulopathy per Agbuduwe, Charles, Basu, Supratik

Obtenir text complet Obtenir text complet Obtenir text complet

Neoplastic plasma cells generate an inflammatory environment within bone marrow and markedly alter the distribution of T cells between lymphoid compartments per Goodyear, Oliver C., Essex, Sarah, Seetharam, Anandram, Basu, Supratik, Moss, Paul, Pratt, Guy

Obtenir text complet Obtenir text complet Obtenir text complet

The UPTAKE study: implications for the future of COVID-19 vaccination trial recruitment in UK and beyond per Sethi, Sonika, Kumar, Aditi, Mandal, Anandadeep, Shaikh, Mohammed, Hall, Claire A., Kirk, Jeremy M. W., Moss, Paul, Brookes, Matthew J., Basu, Supratik

Obtenir text complet Obtenir text complet Obtenir text complet

The UPTAKE study: a cross-sectional survey examining the insights and beliefs of the UK population on COVID-19 vaccine uptake and hesitancy per Sethi, Sonika, Kumar, Aditi, Mandal, Anandadeep, Shaikh, Mohammed, Hall, Claire A, Kirk, Jeremy M W, Moss, Paul, Brookes, Matthew J, Basu, Supratik

Obtenir text complet Obtenir text complet Obtenir text complet

Panobinostat in combination with bortezomib and dexamethasone in multiply relapsed and refractory myeloma; UK routine care cohort per Maouche, Nadjoua, Kishore, Bhuvan, Bhatti, Zara, Basu, Supratik, Karim, Farheen, Sundararaman, Sharadha, Collings, Freya, Tseu, Bing, Leary, Heather, Ryman, Noel, Reddy, Udaya, Vallance, Grant D., Kothari, Jaimal, Ramasamy, Karthik

Obtenir text complet Obtenir text complet Obtenir text complet

Treatment of Acute Renal Failure Secondary to Multiple Myeloma with Chemotherapy and Extended High Cut-Off Hemodialysis per Hutchison, Colin A., Bradwell, Arthur R., Cook, Mark, Basnayake, Kolitha, Basu, Supratik, Harding, Stephen, Hattersley, John, Evans, Neil D., Chappel, Mike J., Sampson, Paul, Foggensteiner, Lukas, Adu, Dwomoa, Cockwell, Paul

Obtenir text complet Obtenir text complet Obtenir text complet

COVID symptoms, testing, shielding impact on patient‐reported outcomes and early vaccine responses in individuals with multiple myeloma per Ramasamy, Karthik, Sadler, Ross, Jeans, Sally, Varghese, Sherin, Turner, Alison, Larham, Jemma, Gray, Nathanael, Barrett, Joe, Bowcock, Stella, Cook, Gordon, Kyriakou, Chara, Smith, Dean, Drayson, Mark, Basu, Supratik, Moore, Sally, McDonald, Sarah, Gooding, Sarah, Javaid, Muhammad K.

Obtenir text complet Obtenir text complet Obtenir text complet

Immune response to COVID‐19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T‐cell response per Ramasamy, Karthik, Sadler, Ross, Jeans, Sally, Weeden, Paul, Varghese, Sherin, Turner, Alison, Larham, Jemma, Gray, Nathanael, Carty, Oluremi, Barrett, Joe, Bowcock, Stella, Oppermann, Udo, Cook, Gordon, Kyriakou, Chara, Drayson, Mark, Basu, Supratik, Moore, Sally, McDonald, Sarah, Gooding, Sarah, Javaid, Muhammad K.

Obtenir text complet Obtenir text complet Obtenir text complet

Vaccine Efficacy after Rituximab Exposure: First Interim Analysis of Virtue Project on Behalf of West Midlands Research Consortium, UK per Shields, Adrian M, Venkatachalam, Srinivasan, Paneesha, Shankara, Ford, Mark, Sheeran, Tom, Kelly, Melanie, Karim, Farheen, Qureshi, Iman, Salhan, Beena, DeSilva, Neelakshi, Stones, Jacqueline, Lee, Sophie, Khawaja, Jahanzeb, Kaudlay, Praveen Kumar, Whitmill, Richard, Nabikakepoto, Ghulam, Faustini, Sian E, Richter, Alex G, Drayson, Mark T, Basu, Supratik

Obtenir text complet Obtenir text complet

SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study per Shields, Adrian M, Venkatachalam, Srinivasan, Shafeek, Salim, Paneesha, Shankara, Ford, Mark, Sheeran, Tom, Kelly, Melanie, Qureshi, Iman, Salhan, Beena, Karim, Farheen, De Silva, Neelakshi, Stones, Jacqueline, Lee, Sophie, Khawaja, Jahanzeb, Kaudlay, Praveen Kumar, Whitmill, Richard, Kakepoto, Ghulam Nabi, Parry, Helen M, Moss, Paul, Faustini, Sian E, Richter, Alex G, Drayson, Mark T, Basu, Supratik

Obtenir text complet Obtenir text complet Obtenir text complet

Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA per Facon, Thierry, Cook, Gordon, Usmani, Saad Z., Hulin, Cyrille, Kumar, Shaji, Plesner, Torben, Touzeau, Cyrille, Bahlis, Nizar J., Basu, Supratik, Nahi, Hareth, Goldschmidt, Hartmut, Quach, Hang, Mohty, Mohamad, Venner, Christopher P., Weisel, Katja, Raje, Noopur, Hebraud, Benjamin, Belhadj-Merzoug, Karim, Benboubker, Lotfi, Decaux, Olivier, Manier, Salomon, Caillot, Denis, Ukropec, Jon, Pei, Huiling, Van Rampelbergh, Rian, Uhlar, Clarissa M., Kobos, Rachel, Zweegman, Sonja

Obtenir text complet Obtenir text complet Obtenir text complet

Efficacy of Isatuximab With Pomalidomide and Dexamethasone in Relapsed Myeloma: Results of a UK-Wide Real-World Dataset per Djebbari, Faouzi, Rampotas, Alexandros, Vallance, Grant, Panitsas, Fotios, Basker, Nanda, Sangha, Gina, Salhan, Beena, Karim, Farheen, Al-Kaisi, Firas, Gudger, Amy, Ngu, Loretta, Poynton, Matt, Lam, Ho Pui Jeff, Morgan, Lowri, Yang, Laura, Young, Jennifer, Walker, Mairi, Tsagkaraki, Ismini, Anderson, Laura, Chauhan, Saleena Rani, Maddams, Rebecca, Soutar, Richard, Triantafillou, Margarita, Prideaux, Steve, Obeidalla, Abubaker, Bygrave, Ceri, Basu, Supratik, Ramasamy, Karthik

Obtenir text complet Obtenir text complet Obtenir text complet